Chad Oh - 21 May 2025 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Reporting relationship: Chief Medical Officer
Issuer ticker: AEON
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2025, 16:56:33 UTC
Prior SEC filing: 04 Sep 2024
Next SEC filing: 11 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Alexander Wilson, as attorney-in-fact for Chad Oh

Key filing fact

Chad Oh filed Form 4 for AEON Biopharma, Inc. (AEON) on 23 May 2025.

Key facts

This page summarizes Chad Oh's Form 4 filing for AEON Biopharma, Inc. (AEON).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 May 2025, 16:56.

Change

Previous filing in this sequence was filed on 04 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001882166 Primary reporting owner

Oh Chad

Relationship: Chief Medical Officer
Address: 5 PARK PLAZA, SUITE 1750, IRVINE
Signature: /s/ Alexander Wilson, as attorney-in-fact for Chad Oh
Signature date: 23 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AEON transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +1,316,872
Change %
Price: $0.000000
Shares after: 1,316,872
Date: 21 May 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,316,872
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") will be settled in cash based on the fair market value of the Issuer's Class A Common Stock on the applicable vesting date.

Footnote F2

25% of the RSUs shall vest on each anniversary of May 21, 2025.